A detailed history of Price T Rowe Associates Inc transactions in Opko Health, Inc. stock. As of the latest transaction made, Price T Rowe Associates Inc holds 436,950 shares of OPK stock, worth $690,381. This represents 0.0% of its overall portfolio holdings.

Number of Shares
436,950
Previous 433,048 0.9%
Holding current value
$690,381
Previous $542,000 20.3%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$1.21 - $1.68 $4,721 - $6,555
3,902 Added 0.9%
436,950 $652,000
Q2 2024

Aug 14, 2024

SELL
$1.21 - $1.42 $15,648 - $18,364
-12,933 Reduced 2.9%
433,048 $542,000
Q1 2024

May 15, 2024

BUY
$0.87 - $1.57 $15,373 - $27,743
17,671 Added 4.13%
445,981 $536,000
Q4 2023

Feb 14, 2024

BUY
$1.23 - $1.63 $35,813 - $47,460
29,117 Added 7.29%
428,310 $647,000
Q3 2023

Nov 14, 2023

SELL
$1.5 - $2.17 $16,498 - $23,867
-10,999 Reduced 2.68%
399,193 $639,000
Q2 2023

Aug 14, 2023

BUY
$1.37 - $2.17 $7,073 - $11,203
5,163 Added 1.27%
410,192 $891,000
Q1 2023

May 15, 2023

BUY
$1.06 - $1.61 $50,065 - $76,043
47,232 Added 13.2%
405,029 $592,000
Q4 2022

Feb 14, 2023

BUY
$1.05 - $2.01 $90,025 - $172,335
85,739 Added 31.51%
357,797 $447,000
Q3 2022

Nov 14, 2022

SELL
$1.81 - $2.81 $6,412 - $9,955
-3,543 Reduced 1.29%
272,058 $515,000
Q2 2022

Aug 15, 2022

BUY
$2.33 - $3.61 $7,213 - $11,176
3,096 Added 1.14%
275,601 $697,000
Q1 2022

May 16, 2022

SELL
$2.87 - $4.93 $34,925 - $59,993
-12,169 Reduced 4.27%
272,505 $937,000
Q2 2021

Aug 16, 2021

SELL
$3.33 - $4.55 $25,051 - $34,229
-7,523 Reduced 2.57%
284,674 $1.15 Million
Q1 2021

May 17, 2021

BUY
$4.19 - $5.99 $197,043 - $281,691
47,027 Added 19.18%
292,197 $1.25 Million
Q4 2020

Feb 16, 2021

BUY
$3.27 - $4.87 $801,705 - $1.19 Million
245,170 New
245,170 $968,000

Others Institutions Holding OPK

About OPKO HEALTH, INC.


  • Ticker OPK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 771,960,000
  • Market Cap $1.22B
  • Description
  • OPKO Health, Inc., a healthcare company, engages in the diagnostics and pharmaceuticals businesses in the United States, Ireland, Chile, Spain, Israel, Mexico, and internationally. The company's Diagnostics segment operates BioReference Laboratories that offers laboratory testing services for the detection, diagnosis, evaluation, monitoring, and...
More about OPK
Track This Portfolio

Track Price T Rowe Associates Inc Portfolio

Follow Price T Rowe Associates Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

News

Stay updated on Price T Rowe Associates Inc with notifications on news.